By Helgi Library - August 11, 2020
Walgreens Boots made a net profit of USD 3,703 mil with revenues of USD 137,412 mil in 2019, down by 30.5% and up by 2....
By Helgi Library - August 11, 2020
Walgreens Boots stock traded at USD 49.8 per share at the end 2019 translating into a market capitalization of USD 45,835 mil. Si...
By Helgi Library - August 11, 2020
Walgreens Boots's net debt stood at USD 41,244 mil and accounted for 170% of equity at the end of 2019. The ratio is up ...
| Profit Statement |
| Balance Sheet |
| Ratios |
| Valuation |
Get all company financials in excel:
Get all company financials in excel:
By Helgi Library - August 11, 2020
Walgreens Boots made a net profit of USD 3,703 mil in 2019, down 30.5% compared to the previous year. Historically, between 1993 and 2019, the company's net profit reached a high of USD 5,326 mil in 2018 and a low of USD 226 mil in 1993. The result implie...
By Helgi Library - August 11, 2020
Walgreens Boots made a net profit of USD 3,703 mil with revenues of USD 137,412 mil in 2019, down by 30.5% and up by 2.10%, respectively, compared to the previous year. This translates into a net margin of 2.69%. Historically, between 1993 and 2019, ...
By Helgi Library - August 11, 2020
Walgreens Boots invested a total of USD 1,510 mil in 2019, up 91.9% compared to the previous year. Historically, between 2009 - 2019, the company's investments stood at a high of USD 2,010 mil in 2016 and a low of USD 787 mil in 2018. ...
By Helgi Library - August 11, 2020
Walgreens Boots stock traded at USD 49.8 per share at the end 2019 implying a market capitalization of USD 45,835 mil. Since the end of 2014, stock has appreciated by -5.88% implying an annual average growth of -1.20% In absolute terms, the value of the company ...
By Helgi Library - August 11, 2020
Walgreens Boots stock traded at USD 49.8 per share at the end 2019 translating into a market capitalization of USD 45,835 mil. Since the end of 2014, the stock has depreciated by 5.88% representing an annual average growth of -1.20%. At the end of 2019, ...
Walgreens Boots Alliance is a pharmacy-led health and wellbeing company. It operates retail drugstores that offer a wide variety of prescription and non-prescription drugs as well as general goods. The Company also offers health services, including primary and acute care, wellness, pharmacy and disease management services, and health and fitness. The company’s portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as increasingly global health and beauty product brands, such as No7, Soap & Glory, Liz Earle, Botanics, Sleek MakeUP and YourGoodSkin.
Walgreens Boots has been growing its sales by 12.1% a year on average in the last 5 years. EBITDA has grown on average by 8.130000000000001% a year during that time to total of USD 7,312 mil in 2019, or 5.32% of sales. That’s compared to 6.16% average margin seen in last five years.
The company netted USD 3,703 mil in 2019 implying ROE of 14.6% and ROCE of 5.83%. Again, the average figures were 15.8% and 8.45%, respectively when looking at the previous 5 years.
Walgreens Boots’s net debt amounted to USD 41,244 mil at the end of 2019, or 170% of equity. When compared to EBITDA, net debt was 5.64x, up when compared to average of 2.40x seen in the last 5 years.
Walgreens Boots stock traded at USD 49.8 per share at the end of 2019 resulting in a market capitalization of USD 45,835 mil. Over the previous five years, stock price fell by 5.88% or -1.20% a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of 11.9x and price to earnings (PE) of 11.6x as of 2019.
Helgi Library 
